Scientific conference spotlights PYC's work on blindness disease treatment
PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
ASB | Ann: ASB Half Year Financial Results 6 February 2019 | 07/02/19 | 0 | 105 | |||
|
|||||||
ASB | Ann: ASB Disclosure Statement 31 December 2018 | 07/02/19 | 0 | 106 | |||
|
|||||||
ASB | Ann: CBA 2019 Half Year Results Profit Announcement | 07/02/19 | 0 | 105 | |||
|
|||||||
ASB | Ann: CBA 2019 Half Year Results ASX Announcement | 07/02/19 | 0 | 108 | |||
|
|||||||
ASB | Ann: CBA 2019 Half Year Results Presentation | 07/02/19 | 0 | 105 | |||
|
|||||||
ASB | Ann: CBA 2019 Basel III Pillar 3 Disclosure as at 31 Dec 2018 | 07/02/19 | 0 | 104 | |||
|
|||||||
ASB | Ann: Redemption of ASB Capital Ltd Perpetual Preference Shares | 07/02/19 | 0 | 106 | |||
|
|||||||
ASB | Ann: Redemption of ASB Capital No.2 Ltd Perpetual Pref Shares | 07/02/19 | 0 | 105 | |||
|
See All Discussions